The CDC's Chief Medical Officer Is Leaving After Less Than Five Months. Satish Pillai Steps In.
Jennifer Shuford, the former Texas health commissioner, leaves the CDC on Nov. 12, the latest senior exit since 2025. Satish Pillai is acting.
Jennifer Shuford, M.D., deputy director and chief medical officer of the Centers for Disease Control and Prevention (CDC), is leaving the agency, with her last day planned for Nov. 12. She joined in June. Capt. Satish Pillai will serve in both roles on an acting basis.
CDC Director Erica Schwartz announced the departure to staff by email on Oct. 27, and a CDC spokesperson confirmed it, NBC News reported. Shuford said she was leaving to spend more time with her family and thanked "President Trump and Secretary Kennedy for giving me the opportunity to help lead CDC." Schwartz wrote that she was "deeply grateful for Dr. Shuford's outstanding leadership." Pillai currently leads the agency's Ebola response, NBC reported, and the CDC plans to search for a permanent successor.
Who is Jennifer Shuford?
Shuford is an epidemiologist who was Texas's chief state epidemiologist during the COVID-19 pandemic and became commissioner of the Texas Department of State Health Services in 2022. She led the state's response to the 2025 West Texas measles outbreak, which caused more than 750 cases and the deaths of two school-age children, according to NBC. President Trump announced her appointment in April alongside Schwartz's nomination as director, The Philadelphia Inquirer reported.
The reason given is personal. The Inquirer noted speculation that she disagreed with an upcoming administration policy and said that was unconfirmed. Demetre Daskalakis, who resigned from the CDC in August 2025 in protest of administration policies, told the Inquirer, "It is highly concerning that the most qualified person in the office of the director is departing the agency."
How does this fit the CDC's turnover?
It is the latest of several senior exits in just over a year. The timeline below is The Script Pad's compilation from the NBC and Inquirer reports.
August 2025: Health Secretary Robert F. Kennedy Jr. fired Director Susan Monarez 29 days into her term; four senior officials resigned afterward, three citing political interference in the agency's science. February 2026: Principal Deputy Director Ralph Abraham stepped down. April 2026: Shuford's appointment and Schwartz's nomination were announced. June 2026: Shuford started; Allison Arwady, director of the National Center for Injury Prevention and Control, announced her departure. August 2026: the Senate confirmed Schwartz, ending about a year without a permanent director. Nov. 12, 2026: Shuford's planned last day, by our count less than five and a half months after she started, and less than five by NBC's count.
A change at the top of the CDC does not change what is in force at the bedside. Recommendations, outbreak guidance and Health Alert Network notices stay as issued until the agency says otherwise.
What else is the CDC handling?
The departure comes as the agency is in a dispute over measles deaths reported by the Pennsylvania Department of Health, the Inquirer reported. The Script Pad covered that outbreak, and the CDC's handling of the death count, in our Oct. 18 report. The acting chief medical officer also leads the agency's Ebola response; the Bundibugyo outbreak is the subject of our clinician checklist, and the agency's vaccine advisory committee has not met this year while litigation over its membership continues.
What it means in clinic
Nothing changes in practice on Nov. 12. Clinicians who rely on the CDC for measles, Ebola and respiratory season guidance should keep using the agency's current clinical pages and Health Alert Network notices and keep their state health department's alerts in view. Watch for who is named to the post permanently, and whether the role stays with a physician epidemiologist.
Reported, fact-checked and edited by The Script Pad's editorial staff. See How we use AI.
This article is for professional education and does not replace clinical judgment. Treatment decisions should be based on the individual patient and current guidelines.
